Get started
Author

Vipendra Kumar

Observed name: Vipendra Kumar (2897249)
ORCID: 0009-0006-3656-0837
Observed ORCID: 0009-0006-3656-0837
OpenAlex ID: A5080601972
Efficient Inhibition of Protein Aggregation, Disintegration of Aggregates, and Lowering of Cytotoxicity by Green Tea Polyphenol-Based Self-Assembled Polymer Nanoparticles
2016 · Koushik Debnath, Shashi Shekhar, et al. · ACS Applied Materials & Interfaces · 129
Azadiradione Restores Protein Quality Control and Ameliorates the Disease Pathogenesis in a Mouse Model of Huntington’s Disease
2018 · Brijesh Kumar Singh, Naman Vatsa, et al. · Molecular Neurobiology · 40
Ube3a deficiency inhibits amyloid plaque formation in APPswe/PS1δE9 mouse model of Alzheimer’s disease
2017 · Brijesh Kumar Singh, Naman Vatsa, et al. · Human Molecular Genetics · 38
PDF
Glycogen synthase protects neurons from cytotoxicity of mutant huntingtin by enhancing the autophagy flux
2018 · Anupama Rai, Pankaj Kumar Singh, et al. · Cell Death and Disease · 37
PDF
Deficiency of Ube3a in Huntington's disease mice brain increases aggregate load and accelerates disease pathology
2014 · Megha Maheshwari, Shashi Shekhar, et al. · Human Molecular Genetics · 34
Withaferin A Induces Heat Shock Response and Ameliorates Disease Progression in a Mouse Model of Huntington’s Disease
2021 · Tripti Joshi, Vipendra Kumar, et al. · Molecular Neurobiology · 33
PDF
Down-Regulation of miRNA-708 Promotes Aberrant Calcium Signaling by Targeting Neuronatin in a Mouse Model of Angelman Syndrome
2019 · Naman Vatsa, Vipendra Kumar, et al. · Frontiers in Molecular Neuroscience · 21
PDF
Rescue of altered HDAC activity recovers behavioural abnormalities in a mouse model of Angelman syndrome
2017 · Imran Jamal, Vipendra Kumar, et al. · Neurobiology of Disease · 21
Simvastatin Restores HDAC1/2 Activity and Improves Behavioral Deficits in Angelman Syndrome Model Mouse
2019 · Vipendra Kumar, Tripti Joshi, et al. · Frontiers in Molecular Neuroscience · 17
PDF
Environmental Enrichment Improves Behavioral Abnormalities in a Mouse Model of Angelman Syndrome
2016 · Imran Jamal, Vipendra Kumar, et al. · Molecular Neurobiology · 16
mGluR7 allosteric modulator AMN082 corrects protein synthesis and pathological phenotypes in FXS
2024 · Vipendra Kumar, Kwan Young Lee, et al. · EMBO Molecular Medicine · 10
PDF
Topoisomerase 1 inhibitor topotecan delays the disease progression in a mouse model of Huntington’s disease
2016 · Shashi Shekhar, Naman Vatsa, et al. · Human Molecular Genetics · 10
PDF
Reversing Pathophysiology in Fragile X Syndrome Mice by Promoting PGC-1α and Mitochondrial Functions
2026 · Anirudh Acharya, Vipendra Kumar, et al. · bioRxiv (Cold Spring Harbor Laboratory)
E3 Ubiquitin Ligase Nedd4‐2 Exacerbates Seizure‐Induced Mitochondrial Defects in an Alzheimer's Disease Mouse Model
2026 · Yingxin Wang, Jiuhe Zhu, et al. · Journal of Neurochemistry
Author response for "E3 Ubiquitin Ligase Nedd4-2 Exacerbates Seizure-induced Mitochondrial Defects in an Alzheimer’s Disease Mouse Model"
2026 · Yingxin Wang, Jiuhe Zhu, et al.
Role of simvastatin in restoration of behavioral and synaptic deficits in Angelman syndrome mouse model
2019 · Vipendra Kumar, Tripti Joshi, et al. · IBRO Reports
PDF
Ube3a deficiency inhibits amyloid plaque formation in APPswe/PS1δE9 mouse model of Alzheimer’s disease
2017 · Brijesh Kumar Singh, Naman Vatsa, et al. · Canadian Journal of Biotechnology
PDF
Works count: 18
Citation count: 406
H-index: 10
I10-index: 12
Year
Topic
Type